Cargando…
The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients
In multiple sclerosis (MS), oligodendrocyte precursor cells (OPCs) are recruited to the site of injury to remyelinate damaged axons; however, in patients this process is often ineffective due to defects in OPC maturation. The membrane receptor GPR17 timely regulates the early stages of OPC different...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123849/ https://www.ncbi.nlm.nih.gov/pubmed/33925469 http://dx.doi.org/10.3390/ijms22094574 |
_version_ | 1783693032149745664 |
---|---|
author | Angelini, Jacopo Marangon, Davide Raffaele, Stefano Lecca, Davide Abbracchio, Maria P. |
author_facet | Angelini, Jacopo Marangon, Davide Raffaele, Stefano Lecca, Davide Abbracchio, Maria P. |
author_sort | Angelini, Jacopo |
collection | PubMed |
description | In multiple sclerosis (MS), oligodendrocyte precursor cells (OPCs) are recruited to the site of injury to remyelinate damaged axons; however, in patients this process is often ineffective due to defects in OPC maturation. The membrane receptor GPR17 timely regulates the early stages of OPC differentiation; however, after reaching its highest levels in immature oligodendrocytes, it has to be downregulated to allow terminal maturation. Since, in several animal models of disease GPR17 is upregulated, the aim of this work was to characterize GPR17 alterations in MS patients. We developed immunohistochemistry and immunofluorescence procedures for the detection of GPR17 in human tissues and stained post-mortem MS brain lesions from patients with secondary progressive MS and control subjects. The inflammatory activity in each lesion was evaluated by immunohistochemistry for the myelin protein MOG and the HLA antigen to classify them as active, chronic inactive or chronic active. Hence, we assessed the distribution of GPR17-positive cells in these lesions compared to normal appearing white matter (NAWM) and white matter (WM) of control subjects. Our data have shown a marked increase of GPR17-expressing oligodendroglial cells accumulating at NAWM, in which moderate inflammation was also found. Furthermore, we identified two distinct subpopulations of GPR17-expressing oligodendroglial cells, characterized by either ramified or rounded morphology, that differently populate the WM of healthy controls and MS patients. We concluded that the coordinated presence of GPR17 in OPCs at the lesion sites and inflamed NAWM areas suggests that GPR17 could be exploited to support endogenous remyelination through advanced pharmacological approaches. |
format | Online Article Text |
id | pubmed-8123849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81238492021-05-16 The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients Angelini, Jacopo Marangon, Davide Raffaele, Stefano Lecca, Davide Abbracchio, Maria P. Int J Mol Sci Article In multiple sclerosis (MS), oligodendrocyte precursor cells (OPCs) are recruited to the site of injury to remyelinate damaged axons; however, in patients this process is often ineffective due to defects in OPC maturation. The membrane receptor GPR17 timely regulates the early stages of OPC differentiation; however, after reaching its highest levels in immature oligodendrocytes, it has to be downregulated to allow terminal maturation. Since, in several animal models of disease GPR17 is upregulated, the aim of this work was to characterize GPR17 alterations in MS patients. We developed immunohistochemistry and immunofluorescence procedures for the detection of GPR17 in human tissues and stained post-mortem MS brain lesions from patients with secondary progressive MS and control subjects. The inflammatory activity in each lesion was evaluated by immunohistochemistry for the myelin protein MOG and the HLA antigen to classify them as active, chronic inactive or chronic active. Hence, we assessed the distribution of GPR17-positive cells in these lesions compared to normal appearing white matter (NAWM) and white matter (WM) of control subjects. Our data have shown a marked increase of GPR17-expressing oligodendroglial cells accumulating at NAWM, in which moderate inflammation was also found. Furthermore, we identified two distinct subpopulations of GPR17-expressing oligodendroglial cells, characterized by either ramified or rounded morphology, that differently populate the WM of healthy controls and MS patients. We concluded that the coordinated presence of GPR17 in OPCs at the lesion sites and inflamed NAWM areas suggests that GPR17 could be exploited to support endogenous remyelination through advanced pharmacological approaches. MDPI 2021-04-27 /pmc/articles/PMC8123849/ /pubmed/33925469 http://dx.doi.org/10.3390/ijms22094574 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Angelini, Jacopo Marangon, Davide Raffaele, Stefano Lecca, Davide Abbracchio, Maria P. The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients |
title | The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients |
title_full | The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients |
title_fullStr | The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients |
title_full_unstemmed | The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients |
title_short | The Distribution of GPR17-Expressing Cells Correlates with White Matter Inflammation Status in Brain Tissues of Multiple Sclerosis Patients |
title_sort | distribution of gpr17-expressing cells correlates with white matter inflammation status in brain tissues of multiple sclerosis patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8123849/ https://www.ncbi.nlm.nih.gov/pubmed/33925469 http://dx.doi.org/10.3390/ijms22094574 |
work_keys_str_mv | AT angelinijacopo thedistributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT marangondavide thedistributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT raffaelestefano thedistributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT leccadavide thedistributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT abbracchiomariap thedistributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT angelinijacopo distributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT marangondavide distributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT raffaelestefano distributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT leccadavide distributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients AT abbracchiomariap distributionofgpr17expressingcellscorrelateswithwhitematterinflammationstatusinbraintissuesofmultiplesclerosispatients |